+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Life Science Tools - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 839 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302818

Global Life Science Tools Market to Reach $226.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Life Science Tools estimated at US$112.4 Billion in the year 2020, is projected to reach a revised size of US$226.2 Billion by 2027, growing at a CAGR of 10.5% over the period 2020-2027. Cell Biology, one of the segments analyzed in the report, is projected to record a 9.8% CAGR and reach US$82.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Genomic segment is readjusted to a revised 11.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $30.4 Billion, While China is Forecast to Grow at 13.7% CAGR

The Life Science Tools market in the U.S. is estimated at US$30.4 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$47.9 Billion by the year 2027 trailing a CAGR of 13.7% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$32.8 Billion by the year 2027.

Proteomics Segment to Record 11.5% CAGR

In the global Proteomics segment, USA, Canada, Japan, China and Europe will drive the 11.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.4 Billion in the year 2020 will reach a projected size of US$29.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 13.1% CAGR through the analysis period.

Select Competitors (Total 308 Featured)

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Life Science Tools

What is the estimated value of the Global Market for Life Science Tools?

The Global Market for Life Science Tools was estimated to be valued at $112.4 Billion in 2020.

What is the growth rate of the Global Market for Life Science Tools?

The growth rate of the Global Market for Life Science Tools is 10.5%, with an estimated value of $226.2 Billion by 2027.

What is the forecasted size of the Global Market for Life Science Tools?

The Global Market for Life Science Tools is estimated to be worth $226.2 Billion by 2027.

Who are the key companies in the Global Market for Life Science Tools?

Key companies in the Global Market for Life Science Tools include Abbott Laboratories Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., Bruker Corporation, Carl Zeiss AG, Eppendorf SE and La Roche AG.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • Year 2021 in Review and Near Term Outlook
  • Exhibit 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2023
  • Impact of COVID-19 on Life Sciences Sector
  • Exhibit 2: Life Science Tools - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2022 (E)
  • Recent Market Activity
  • World Brands
  • Life Science Tools: A Prelude
  • Market Outlook
  • Cell Biology Holds Significant Revenue Stake
  • Intertwined Factors with Major Implications for Life Science Domain & Related Tools
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Trends in Life Science Research Sector Support Demand
  • 3D Cell Culture Transforms Life Sciences Industry
  • Exhibit 3: Global 3D Cell Culture Market in US$ Million: 2020 - 2027
  • Increasing Demand for 3D Cell Culture in Drug Discovery
  • Use of 3D Cell Culture for Regenerative Medicine
  • Proteomics Emerges as an Important Research Tool in Battle against COVID-19
  • Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics
  • Proteomics Profiling to Expedite Drug Discovery
  • Proteomics at the Fore with Latest Advances
  • Mass Spectrometry (MS) Expands Application of Proteomics
  • AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
  • mRNA Technology Gains Spotlight in Life Sciences
  • Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR
  • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
  • Exhibit 4: Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025
  • Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests
  • Next Generation Sequencing Drives the Market Growth
  • R&D Activity Remains Vibrant in NGS
  • The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services
  • Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs
  • Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools
  • Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects
  • Exhibit 5: Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026
  • Liquid Chromatography Drives Growth in New Application Markets
  • Innovative HPLC Products Inject New Growth
  • Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity
  • Exhibit 6: Key Initiators of Digital Transformation in Life Sciences
  • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
  • Exhibit 7: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
  • Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry
  • Exhibit 8: Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques
  • Miniature Mass Spectroscopy Instruments Get Popular
  • Increase in Healthcare Spending to Propel Demand for Life Science Tools
  • Exhibit 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Analytics
CANADA
JAPAN
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Analytics
CHINA
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Analytics
EUROPE
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Analytics
FRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPEASIA-PACIFICAUSTRALIA
INDIA
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Market Analytics
SOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAMIDDLE EASTAFRICA
IV. COMPETITION
  • Total Companies Profiled: 308

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.